Skip to content

A parallel-group comparative study on "everyday fatigue" in PapriX

A parallel-group comparative study on "everyday fatigue" in PapriX - A parallel-group comparative study on "everyday fatigue" in PapriX

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000056794
Enrollment
30
Registered
2025-01-27
Start date
2025-02-04
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult men and women

Interventions

Take one soft capsule containing paprika xanthophyll (9mg/day) for 8 weeks Take one placebo soft capsule for 8 weeks

Sponsors

Glico Nutrition Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Healthy men and women between the ages of 30 and 59

Exclusion criteria

Exclusion criteria: Those currently undergoing drug treatment for any illness Those undergoing hormone replacement therapy Those who have undergone or are undergoing cosmetic medical treatment that affects the face within the past 5 years Those who cannot refrain from special care that is not performed daily during the study period Those who cannot refrain from taking beauty supplements or drinks during the study period Those with a history of food allergies Those taking medicines (whose efficacy and effect is to recover from fatigue or provide nutrition during physical fatigue) that may affect the study Those who cannot stop taking health foods (including foods for specified health uses and foods with functional claims) or designated quasi-drugs that may affect the study Those who are aware of lower back pain, joint pain, lumbar hernia, lower limb disease, palpitations, or anemia Pregnant or breastfeeding people Those who may significantly change their lifestyle during the study period (long-term travel, etc.) Those participating in studies that involve the intake of other foods or drugs

Design outcomes

Primary

MeasureTime frame
VAS Survey

Secondary

MeasureTime frame
Ramp stress test, oxygen intake, heart rate, blood pressure, blood oxygen saturation, Skin moisture content, Transepidermal water loss, elasticity, facial image diagnosis

Countries

Japan

Contacts

Public ContactYumi Hosogi

Glico Nutrition Co., Ltd. R&D Center

yumi.hosogi@glico.com050-1744-4293

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026